This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
 
Aetna Thrives Under Obamacare, Profits Rise in Q2

Aetna's Q2 profits came in at $1.52 a share as revenue climbed 26% to $14.5 billion. Aetna also said it was optimistic about the remainder of 2014.

Misfiring at Earnings Time? Sturm Ruger is the Chart of the Day

In the wake of a spate of school shootings, the stock in gun makers like Sturm, Ruger & Co. took off, perhaps surprising some.

Merck Earnings, Twitter User Growth & EPS, Jim Cramer's New Vale Pick

Tuesday will be a big day for a number of companies, with drugmakers Merck and Pfizer expected to report.

European Stocks Back in Positive Territory as Strong Corporate News Offsets Concerns About Imminent EU, US Sectoral Sanctions Against Russia

European stocks returned to positive territory Tuesday, as strong corporate news offset concerns about imminent sanctions against key sectors of Russia’s economy.

Zillow CEO Spencer Rascoff Says Housing is Localized, Complicated

Zillow chief executive officer Spencer Rascoff weighs in on the choppy picture of the housing market right now.

Real Money Previews

Williams: No Gas for EU!

U.S. liquefied natural gas is not an option for Europe.

Cramer: Navigating the Twitter Minefield

If you insist on playing it, recognize the 50/50 nature of the scenario.

Rag Doll; Taking Another Crack at Citi: Best of Kass

In highlights from his trading diary of the past week, Doug Kass examines how the market has begun to look ragged, and discusses why his view of Citigroup has changed.

Mad Money Recap

'Mad Money' Lightning Round: Don't Sell General Electric Just Yet

Cramer thinks FleetCor Technologies is fabulous and he's not giving up on Exelixis at the moment.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

3 Big M&A Stocks on Traders' Radars

Here's how to trade some of the most active stocks on the market today.

4 Hot Stocks to Trade (or Not)

Here's how to trade some of the most active stocks on the market today.

4 Tech Stocks Rising on Unusual Volume

Keep these tech stocks rising on unusual volume on your radar.

5 Rocket Stocks to Buy for August Gains

These stocks have both short-term gain catalysts and longer-term growth prospects.

3 Huge Stocks on Traders' Radars

Here's how to trade some of the most active stocks on the market today.

MainStreet

Young Americans Prefer Bank Investments, Not Stock Market

That's a problem, because younger Americans aren't going to meet their giant retirement savings burden with low-yielding cash investments.

What's Really Raising Your Life Insurance Costs

Your age, sex and whether you smoke can hike your insurance costs more than you might guess. But there are ways to lower those costs too.

NFL Absolutely Owns August Television

The NFL preseason kicks off with Sunday's Hall of Fame game, but even those early matchups get bigger ratings than anything else networks can offer.

How Beer and Garlic Breath Built Gordon Biersch

Brewer Gordon Biersch has pubs around the globe, garlic fries that are a major league staple and beer that's held up for 25 years. It's a tough blueprint to follow.

5 Land Mines to Avoid in Funding Your 401(k)

Way too many investors make mistakes over and over again that could easily reduce the value of their 401(k) plans.

Biotech

Galectin Pays Stock Promoters to Entice Retail Investors

Like Galena BioPharma and The DreamTeam Group, Galectin is also paying for a promotional campaign designed to entice retail investors into buying its stock.

Access to Horizon Pharma Drugs Cut By Two Leading PBMs

Express Scripts and CVS Caremark are the largest and second-largest pharmacy benefits managers in the U.S. Both have been aggressive with efforts to rein in ever-escalating drug prices.

FDA Rejects AcelRx Painkiller Dispensing Device (Update)

AcelRx believes it can gather all the requested information and re-submit Zalviso to the FDA before the end of the year.

Beyond Wall St.

Deal News

Zillow CEO Spencer Rascoff on the Benefits of $3.5B Trulia Buyout

Zillow CEO Spencer Rascoff tells TheStreet's Brittany Umar how the $3.5 billion acquisition of Trulia will enhance the company's business.

21st Century Fox Sweetens Time Warner Deal With Board Seats

In its latest move to tempt Time Warner to reconsider its buyout offer, 21st Century Fox will reportedly allow Time Warner shareholders a spot on the board.

Icahn Sees New Buyers for Family Dollar After $8.5 Billion Dollar Tree Bid

Dollar General remains a better buyer of Family Dollar, even after the latter said on Monday it would merge with Dollar Tree in a $8.5 billion cash and stock deal.

TheStreetTV
Spin Space

Jim Cramer

Cramer: Navigating the Twitter Minefield

If you insist on playing it, recognize the 50/50 nature of the scenario.

Herb Greenberg

Greenberg: An Inflection Point for Herbalife?

Herbalife surprised investors not with lower-than-expected profit but with revenue, an ominous sign of a slowing growing.

Stephanie Link

Link: Waddell & Reed Offers Growth at a Nice Price

This asset manager's stock pullback looks like an opportunity.

Chris Ciaccia

Is Amazon Trying To Do Too Much?

The giant online retailer sells hardware, software - nearly everything you can think of and more. But, has Amazon lost its focus?

Adam Feuerstein

Galectin Pays Stock Promoters to Entice Retail Investors

Like Galena BioPharma and The DreamTeam Group, Galectin is also paying for a promotional campaign designed to entice retail investors into buying its stock.

Laurie Kulikowski

El Pollo Loco Stock Surges 60% on IPO, But Is It a Buy?

El Pollo Loco surged 60% on its first day of trading. The fast-casual chicken chain raised $107 million from pricing 7.14 million shares at $15 a share.

Dan Freed

$25 Billion Deal and JPMorgan Stumble to Aid of Bronx Homeowner

The mortgage settlement with JPMorgan and four other banks included very little cash and led one Bronx woman down a circuitous, two-year path before her loan could be modified.

Rocco Pendola

How Netflix Taught Me a Pandora Lesson

Changing your position on a company or stock -- even frequently -- makes more sense than marrying yourself to emotional arguments.

Ted Reed

United Airlines Results Impress Wall Street; Pilots Are Doubtful

United Airlines' second quarter results convinced many analysts that the carrier has turned the corner after a difficult merger. But United pilots remain skeptical.

Leon Lazaroff

Comcast Is Now the Center Which the World Revolves Around

Comcast adds more broadband subscribers than forecast in its second quarter, possibly weakening its argument that it needs to acquire Time Warner Cable to defend its business.

Submit an article to us!
DOW 16,982.59 +22.02 0.13%
S&P 500 1,978.91 +0.57 0.03%
NASDAQ 4,444.9090 -4.6550 -0.10%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs